Fragile X: New drug strategy corrects behavior/biochemical measures in mouse model

(Emory Health Sciences) Research in mice shows that a pharmacological strategy can alleviate multiple behavioral and cellular deficiencies in a mouse model of fragile X syndrome, the most common inherited form of intellectual disability.

Comments